Menu
Recruiting NCT07346560

1ry Versus 2ry ILM Peeling in RD

No phase Interventional Retinal Detachment Rhegmatogenous ILM Peeling

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Primary ILM peeling, Secondary ILM peeling.
Who it may be relevant to
Registry conditions: Retinal Detachment Rhegmatogenous, ILM Peeling. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Primary Versus Secondary Internal Limiting Membrane Peeling in Uncomplicated Retinal Detachment

Overview

Patients with uncomplicated rhegmatogenous retinal detachment will be recruited. All eyes will underwent 23G PPV with silicon oil tamponade. The eyes will be classified into two groups according to the timing of ILM peeling. Group A, ILM peelin will be performed during the first intervention, while in group B, it will be done at the time of silicon oil extraction.

Interventions

  • Procedure Primary ILM peeling
    ILM peeling during the 1st surgical intervention for rRD
  • Procedure Secondary ILM peeling
    ILM peeling is delayed for the time of silicon oil extraction

Primary outcome measures

  • Incidence of complications [Time frame: From enrollment till 3 months postoperative]

Eligibility criteria

Inclusion criteria

  • Patients with uncomplicated rhegmatogenous retinal detcahment.

Exclusion criteria

  • PVR
  • Recurrent RD
  • Tractional RD
  • Macular hole RD
  • Scleral buckling is indicated
  • Macular scarring
  • Previous PPV

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Sohag Faculty of Medicine — Sohag

Identifiers

NCT: NCT07346560 · Soh-Med-25-12-8PD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗